ALNYLAM PHARMACEUTICALS, INC. Equity Method Investment, Ownership Percentage
ALNYLAM PHARMACEUTICALS, INC. (ALNY) had Equity Method Investment, Ownership Percentage of 12.00% as of 2014-12-31, per its 10-K filed 2015-02-13.
Discontinued › Notes › Investments
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2015-02-13
- 2014-12-31: Equity Method Investment, Ownership Percentage 12.00%.
- 2012-09-30: Equity Method Investment, Ownership Percentage 44.00%.
- 2012-06-30: Equity Method Investment, Ownership Percentage 44.00%; Equity Method Investment, Ownership Percentage as first filed 45.00%.
| Period end | Equity Method Investment, Ownership Percentage | Equity Method Investment, Ownership Percentage as first filed |
|---|---|---|
| 2014-12-31 | 12.00% 10-K · filed 2015-02-13 | |
| 2012-09-30 | 44.00% 10-K · filed 2015-02-13 | |
| 2012-06-30 | 44.00% 10-Q · filed 2012-11-05 | 45.00% 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |